Latest Hycult Biotech news

Introducing a new blocking antibody targeting complement C5, now available for preclinical research! Complement C5 plays a crucial role in many disease processes, and this new antibody offers the option to mimic blocking of terminal complement pathway. But that's not...

With this enhanced partnership, Hycult Biotech is leveraging Bioz' innovative product-specific article recommendations to guide customers in selecting reliable experimentation techniques and products, ultimately saving time and resources. Customers can now access product use-cases on Hycult Biotech's website through Bioz...

Hycult Biotech has developed a new ELISA kit (cat.# HK2002) for detection of intact mouse C3 and that does not react with C3 fragments. Together with our mouse C3b specific ELISA (cat.# HK216), you will be able to quantify specific...

Clinical validation of C1-INH complex assays in: COVID-19 and MIS-C  Hycult Biotech has developed new ELISA kits to monitor early classical pathway activation (via C1s/C1-INH complex), or early lectin pathway activation (via MASP-1/C1-INH complex). The tools are useful to investigate...

Calprotectin is a heterocomplex of the S100A8 and S100A9 proteins that is contained within the cytosol of neutrophils. When neutrophil migration takes place during an inflammatory response, calprotectin is released at the site of inflammation where it has a regulating...

Welcome to Biocult Biocult is an internationally operating company with 20 years’ experience in upscaling of monoclonal antibodies. Since Biocult was established in 1992, we have processed over 200 different cell lines including hybridoma’s, transfectoma’s. BHK, CHO and PerC6 cells....